EP2125698
Tvívetnismerkt d9-venlafaxín
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
13.3.2008EP published:
31.8.2016EP application number:
08732084.2
EP translation filed:
19.10.2016Grant published:
15.11.2016EPO information:
European Patent Register
Max expiry date:
12.3.2028Expiry date:
12.3.2019
Title:
DEUTERATED d9-VENLAFAXINE
Timeline
Today
13.3.2008EP application
31.8.2016EP Publication
19.10.2016Translation submitted
15.11.2016Registration published
12.3.2019Expires
Owner
Name:
Auspex Pharmaceuticals, Inc.Address:
3333 North Torrey Pine Court, Suite 400, 92037, La Jolla, CA, US
Inventor
Name:
GANT, Thomas, G.Address:
Vista, CA, US
Name:
SEPEHR, SarsharAddress:
Vista, CA, US
Name:
WOO, Soon, HyungAddress:
Vista, CA, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
895049 PDate:
15.3.2007Country:
US
Number:
944399 PDate:
15.6.2007Country:
US
Classification
Categories:
C07C 217/74, C07C 215/64, C07D 265/16, C07B 59/00, C07C 211/64
Annual fees
Number
Paid
Expires
Payer
Number: 10
Paid: 16.2.2017
Expires: 12.3.2018
Payer: G. H. Sigurgeirsson
Number: 11
Paid: 20.2.2018
Expires: 12.3.2019
Payer: G. H. Sigurgeirsson